Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzimidazole compounds as ORL1-receptor agonists

Benzimidazole compounds as ORL1-receptor agonists

US Patent 6861425 · Granted Mar 1, 2005

Estimated economic value: $134,880,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetrahydroquinoline derivatives as P2X7 receptor antagonists2025
Tetrahydroquinoline derivatives as P2X7 receptor antagonists2021
Hard surface detergent composition2021
Detergent composition for hard surfaces2019
5-HT4 receptor agonist for gastroparesis2017
Polymorph form of 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}m2015
Picolinamide derivatives as TTX-S blockers2015
Benzisoxazole derivatives2014
Picolinamide derivatives as TTX-S blockers2014
Oxyindole derivatives with motilin receptor agonistic activity2014
Imidazopyridine compounds as 5-HT4 receptor agonists2006
N-substituted piperidinyl-imidazopyridine compounds as 5-HT4 receptor modulators2005